FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,063 letters match. Newest first.

  1. Vintage Chemical Inc.

    FDA warned Vintage Chemical after an inspection found over-the-counter hand soap and sanitizer made on equipment shared with industrial cleaners.

    High risk
  2. Carbon Fire, LLC

    FDA told Carbon Fire its 213° Metabolism Boosting Complex is adulterated because N-Methyltyramine lacks a required safety notice.

    Medium
  3. Mariscos Perla Mar S. de R.L.

    FDA found Mariscos Perla Mar's seafood safety plans missing Clostridium botulinum controls and sanitation records incomplete for frozen lobster and conch.

    High risk
  4. ISPE Produce, Inc.

    ISPE Produce, a Texas importer, had no FSVP for imported fresh tomatoes, bell peppers and lettuce, FDA found.

    Medium
  5. Pingdingshan Tianjing Plant Albumen Co., Ltd.

    FDA cited Pingdingshan Tianjing Plant Albumen, a Chinese maker of ready-to-eat soy protein isolate, for insanitary conditions and unsupported test results on certificates.

    High risk
  6. Juquilita Mexican Imports LLC

    FDA found Juquilita Mexican Imports lacked a Foreign Supplier Verification Program for imported cheese, mole, and seeds.

    Medium
  7. Always Fresco LLC

    Always Fresco LLC imported fresh carrots, cilantro, and squash without developing or following a required foreign supplier verification program.

    Medium
  8. Korean Food, Inc.

    FDA inspected Korean Food, Inc.'s Texas sprout and kimchi facility and found Listeria monitoring gaps, insanitary conditions, and misbranded kimchi labels.

    High risk
  9. Zen Enterprises LLC

    Zen Enterprises failed to correct drug listing files that named a manufacturer not involved in making its balms and hand sanitizers.

    Low
  10. Dr Sankunni’s Ayurvedic Research Foundation Private Ltd.

    Dr Sankunni's Ayurvedic Research Foundation failed to correct drug listing and registration errors for its balms and hand sanitizer.

    Low
  11. Northern VA Compounders PLLC, dba Akina Pharmacy

    FDA warns Akina Pharmacy over unsafe production of compounded drugs and sterility risks.

    High risk
  12. C&T Dream Co., Ltd.

    C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.

    High risk
  13. Natco Pharma Limited

    FDA warned Natco Pharma of adulterated drugs after finding dirty equipment and weak investigations at an India plant.

    High risk
  14. Master Paints & Chemicals Corp.

    FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.

    High risk
  15. La Sucursal Produce Inc.

    La Sucursal Produce lacked FSVP for imported husk tomato, green onion, and peas and failed to register its Los Angeles facility.

    Medium
  16. Appleton City Feed Service LLC

    FDA warned Appleton City Feed Service, a Missouri medicated feed mill, of pest, cross-contamination and drug-combination risks in animal feed.

    High risk
  17. FirstCham Co., Ltd.

    FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.

    High risk
  18. Kilitch Healthcare India Limited

    FDA warns Kilitch Healthcare India over insanitary sterile drug manufacturing and falsified environmental monitoring data.

    High risk
  19. Bodywell Natural Skin Care Inc.

    FDA warned Bodywell Natural Skin Care that its OTC hand sanitizer and Dermalere creams were adulterated due to CGMP failures and unapproved drug claims.

    High risk
  20. Deqing Jiarou Daily Chemical Co., Ltd.

    Deqing Jiarou failed current good manufacturing practice (CGMP) for OTC hand sanitizer, including no methanol testing of ethanol.

    High risk
  21. Higley Industries, Inc.

    FDA warns Higley Industries over CGMP failures in OTC drug manufacturing, including untested ethanol and glycerin.

    High risk
  22. Sol-Millennium Medical, Inc.

    Sol-Millennium marketed modified syringes and needles without required FDA clearance and had quality-system and reporting violations.

    High risk
  23. Dream Wholesale, Inc

    Dream Wholesale, an importer of frozen spinach and chickpeas, lacked required Foreign Supplier Verification Program (FSVP) checks.

    High risk
  24. Agila Corporation dba Woody’s Pet Food Deli

    FDA found Salmonella and Listeria in Woody's raw pet food and an unapproved additive in use.

    High risk
  25. Healthtex Distributors, Inc.

    FDA found Healthtex Distributors' dietary supplements adulterated for CGMP failures and misbranded for labeling violations.

    Medium
  26. LightEyez Limited

    LightEyez eye drops sold in the U.S. were contaminated with microbes, and FDA cited unapproved new drug claims for its eye drops.

    High risk
  27. Amman Pharmaceutical Industries

    FDA warned Amman Pharmaceutical Industries after a 2023 inspection found sterile drug manufacturing and data integrity failures.

    High risk
  28. EzriCare LLC

    EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.

    High risk
  29. Delsam Pharma LLC

    Delsam Pharma distributed non-sterile, contaminated artificial tears and eye ointment made by its contract manufacturer, FDA found.

    High risk
  30. Pt Dua Kelinci

    FDA found Pt Dua Kelinci made ready-to-eat snacks under insanitary conditions, with dirty equipment and allergen cross-contact risks.

    High risk
  31. Madhu Instruments Private Limited

    FDA cites Madhu Instruments in New Delhi for insanitary conditions in sterile drug manufacturing and places it on import alert.

    High risk
  32. QuVa Pharma, Inc.

    FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.

    High risk
  33. Iowa Egg Company Inc.

    Iowa Egg Company Inc. shell egg farm cited for Salmonella Enteritidis prevention, temperature, pest, testing and record violations.

    High risk
  34. Indian Groceries and Spices, Inc.

    FDA says Indian Groceries and Spices lacked required foreign supplier checks for imported cumin, chili powder, and mung beans.

    Medium
  35. Ehy Holdings, LLC

    FDA warned Ehy Holdings over unupdated drug listings for nicotine patches and creams, calling products misbranded.

    Low
  36. Les Importations Herbasanté Inc.

    Canadian contract maker of homeopathic drugs, including children's products, skipped ingredient testing and process validation, FDA says.

    High risk
  37. Inmar Supply Chain Solutions, LLC

    FDA found severe rodent infestation at Inmar warehouse, adulterating stored foods, over-the-counter drugs, and devices.

    High risk
  38. Nantong Furuida Packaging Products Co., Ltd.

    Nantong Furuida, an over-the-counter drug manufacturer, failed required manufacturing controls and methanol checks, leading to an FDA import alert.

    High risk
  39. A True Move LLC

    FDA warns Houston importer A True Move for lacking FSVP plans for imported banana sodas, lollipops, and tomato paste.

    Medium
  40. JJR Global Inc.

    FDA warns JJR Global over missing FSVP for imported chutneys and other foods.

    Medium
  41. Cavevi Naturals LLC

    FDA warns Cavevi Naturals it imported candy and Cheetos without required foreign supplier food-safety verification.

    Medium
  42. Glicerinas Industriales, S.A. de C.V.

    FDA warned Glicerinas Industriales over CGMP failures in repackaged glycerin and propylene glycol, including DEG/EG testing and particulate contamination.

    High risk
  43. ReConserve Inc.

    FDA warned ReConserve Inc. that animal-food ingredients stored outdoors uncovered were contaminated and its preventive controls were inadequate.

    High risk
  44. Prime Lab LLC

    Prime Lab LLC failed U.S. drug manufacturing quality rules for over-the-counter hand soaps and sanitizers, including raw-material testing and shared toxic equipment.

    High risk
  45. Curexa – East, LLC dba Curexa

    Curexa - East made compounded drugs under insanitary conditions, with contamination and inadequate cleaning, FDA says.

    High risk
  46. Kimera Labs, Inc.

    FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.

    High risk
  47. Patcos Cosmetics Pvt. Ltd.

    Patcos Cosmetics, an Indian OTC drug maker, failed to test high-risk ingredients for DEG/EG and lacked quality-unit oversight.

    High risk
  48. Omeza LLC

    FDA warned Omeza LLC over mold, insects and animal waste in drug manufacturing areas and unapproved nonprescription drugs.

    High risk
  49. Dextrum Laboratories Inc.

    FDA found Dextrum Laboratories, an over-the-counter drug contract manufacturer, failed identity testing, toxic glycol checks, water monitoring, and process validation.

    High risk
  50. US Gulf Coast Trading Co., Inc.

    US Gulf Coast Trading Co. warehouse in Houston held food amid widespread rodent filth and insanitary conditions.

    High risk